Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Mouth Neoplasms 1Laryngeal Neoplasms 1Esophageal Neoplasms 1Alcohol Drinking 1

Interventions

Cisplatin 35Radiotherapy 20Magnetic Resonance Spectroscopy 19Cetuximab 17Specimen Handling 15pembrolizumab 13Carboplatin 13Radiotherapy, Intensity-Modulated 12Fluorouracil 12Docetaxel 121,2-diaminocyclohexaneplatinum II citrate 10Radiation 9Platinum 9Paclitaxel 8Surgical Procedures, Operative 7Drug Therapy 6Biopsy 6Taxes 5toripalimab 4X-Rays 4Standard of Care 4Fluorodeoxyglucose F18 4Celecoxib 4(225)Ac-DOTA-c(RGDyK) 4cemiplimab 3Nutritional Status 3Laser Therapy 3Interviews as Topic 3Hydroxyurea 3130-nm albumin-bound paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Laryngeal Neoplasms × Alcoholic Beverages × Clear all
NCT06129487 2025-11-14

Evaluations of Alcohol Warning Labels

University of Connecticut

Phase NA Completed
1,053 enrolled 15 charts
GastrointestinalHead & Neck

Alcohol Drinking, Esophageal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡